These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5877674)

  • 1. [On the effect of corticoid administration on creatine phosphokinase in progressive muscular dystrophy].
    Barthelmai W
    Verh Dtsch Ges Inn Med; 1965; 71():624-6. PubMed ID: 5877674
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
    Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined use of anabolic steroids and digitoxin in progressive muscular dystrophy].
    Yamamoto H; Sugita H; Furukawa T
    Iryo; 1966 Jul; 20(7):704-8. PubMed ID: 5981771
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anabolic steroid hormones and progressive muscular dystrophy].
    Beckmann R
    Dtsch Med Wochenschr; 1972 Feb; 97(6):213. PubMed ID: 5058209
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of Erb's progressive muscular dystrophy].
    Suchenwirth R
    Munch Med Wochenschr; 1972 Jun; 114(22):1071. PubMed ID: 5068025
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H; Keresztes L; Stenzel K
    Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract]   [Full Text] [Related]  

  • 7. Anabolic steroids in the management of muscular dystrophy.
    Charash L
    Pediatrics; 1965 Sep; 36(3):402-5. PubMed ID: 5829332
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the treatment of progressive muscle dystrophy with an anabolic steroid].
    Ernst K
    Z Arztl Fortbild (Jena); 1966 Apr; 60(7):389-90. PubMed ID: 5983564
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progressive muscular dystrophy].
    Tsuji S; Kato F; Osawa K
    Naika; 1967 Jun; 19(6):1301-3. PubMed ID: 4865513
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significances of the elevated activity of serum creatine phosphokinase and transaminase in progressive muscular dystrophy].
    Kondo F; Ikeda M; Abe E; Mue S
    Iryo; 1966 Jul; 20(7):683-93. PubMed ID: 5981769
    [No Abstract]   [Full Text] [Related]  

  • 12. [Our experience in the treatment of progressive muscular dystrophy].
    Buscaino GA
    Acta Neurol (Napoli); 1966; 21(2):133-50. PubMed ID: 5961587
    [No Abstract]   [Full Text] [Related]  

  • 13. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy.
    Nakane K
    Nagoya Med J; 1972 Feb; 17(3):203-16. PubMed ID: 5050757
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment problems using anabolic steroids in progressive muscular dystrophy].
    Badalian LO; Temin PA; Mukhin KIu
    Klin Med (Mosk); 1984 Nov; 62(11):23-9. PubMed ID: 6394898
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of progressive muscular dystrophy with anabolics and uridine-5-triphosphoric acid].
    Valente VL; Caprarulo CC; Luchetta MR; Nenkies L; Miani J; De Zubizarreta CS
    Prensa Med Argent; 1966 May; 53(20):1130-4. PubMed ID: 5916532
    [No Abstract]   [Full Text] [Related]  

  • 16. The value of determination of serum creatine phosphokinase activity in detection of carriers of progressive muscular dystrophy.
    Hetnarska L
    Pol Med J; 1968; 7(1):224-7. PubMed ID: 5650194
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormone therapy of muscular atrophy].
    Oimori M; Goto T; Tateiwa M; Mori H; Takahashi K
    Iryo; 1969 Oct; 23(10):1312-8. PubMed ID: 4312356
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tests of serum creatine phosphokinase activity in patients with progressive muscular dystrophy and their relatives for the detection of genetic carriers].
    László A; Salgó L
    Orv Hetil; 1981 Jun; 122(24):1453-6. PubMed ID: 7290660
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progressive muscular dystrophy and creatine phosphokinase (author's transl)].
    Ebashi S
    Nihon Naika Gakkai Zasshi; 1977 Jul; 66(7):763-8. PubMed ID: 915367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.